Press Releases

 Filter by Provider

Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today announced that it will release its second quarter financial results and business highlights before the market opens on Wednesday, August 6, 2025 via press release, which will be available on the Company’s website at www.geron.com/investors. Geron will host a conference call to discuss the financial results as well as business highlights at 8:00 a.m. Eastern Time.

DeciBio Consulting LLC, a leading market intelligence and strategy consulting firm, announced the publication of its first edition, “Pharma R&D Services Market Report (2024-2029).” This comprehensive report forecasts the global pharma R&D services market to reach approximately $129 billion by 2029, growing at a compound annual growth rate (CAGR) of 5% from an estimated $101 billion in 2024.

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming Canaccord Genuity 45th Annual Growth Conference.

Netsmart ranks as top EHR software in 2025's Top HIT Vendor for Inpatient Behavioral Health Systems

Advanced robotics to accelerate propagation, reduce carbon footprint, and scale plant-based materials faster than ever

Divcon Controls, a leading innovator in mission critical Building Management System (BMS) and Electrical Power Monitoring System (EPMS) solutions, today announced its instrumental role in development of the Aligned Data Centers’ Advanced Cooling Lab, which recently opened in Phoenix, AZ. This collaboration highlights Divcon Controls’ commitment to developing sophisticated control solutions specifically designed to manage the unique and evolving challenges of mechanical assets within liquid-cooled data center environments, critical for the demands of Artificial Intelligence (AI) and High-Performance Computing (HPC), all while emphasizing sustainable operations.

Similarweb’s new GenAI Intelligence Toolkit is an innovative solution combining AI Brand Visibility and AI Traffic, letting companies see how they are represented on AI platforms and the value of AI-generated traffic to their digital marketing and sales.

The new location serving a full menu of breakfast, brunch and lunch opens its doors on Monday, July 28th in Austin, Texas

Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical company using artificial intelligence, machine learning and genomic data to transform the cost, pace and timeline of oncology drug discovery and development, today announced the appointment of Lee T. Schalop, MD, to its Board of Directors.

PRINCETON, N.J., July 28, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative treatments for urothelial and specialty cancers, today announced the publication in Reviews in Urology of results from a Phase 3b study evaluating the feasibility of administering ZUSDURI™ (mitomycin) for intravesical solution (formerly known as UGN-102) in the home setting. The study, titled "Home Instillation of UGN-102 for Primary Chemoablation of Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer: A Single-Arm, Open-Label, Phase 3b Trial," demonstrated that trained home health professionals (HHPs) can safely and effectively administer ZUSDURI outside of a traditional clinical setting.

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Replimune Group, Inc. (“Replimune” or the “Company”) (NASDAQ: REPL) between November 22, 2024 and July 21, 2025, inclusive, alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its senior officers (the “Complaint”).

BRIDGEWATER, N.J., July 28, 2025 (GLOBE NEWSWIRE) -- Synchronoss Technologies Inc. (“Synchronoss” or the “Company”) (Nasdaq: SNCR), a global leader and innovator in Personal Cloud platforms, will hold a conference call on Monday, August 11, 2025 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss its financial results for the second quarter ended June 30, 2025. Financial results will be issued in a press release prior to the call.

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Tempus AI, Inc. (“Tempus” or the “Company”) (NASDAQ: TEM) between August 6, 2024 and May 27, 2025, inclusive.

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of PepGen Inc. (“PepGen” or the “Company”) (NASDAQ: PEPG) between March 7, 2024 and March 3, 2025, inclusive.

LEIDEN, Netherlands & CAMBRIDGE, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today announced that it will participate in the RNA Editing Summit taking place July 29-31, 2025, in Boston, MA.

STMicroelectronics Announces Status ofCommon Share Repurchase Program

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG) between January 5, 2023 and June 3, 2025, inclusive.

Rehovot, Israel, July 28, 2025 (GLOBE NEWSWIRE) --  Steakholder Foods Ltd. (Nasdaq: STKH), a global leader in 3D-printing technology for structured alt-protein production, announced today that it has received a positive Written Opinion from the International Searching Authority (ISA) regarding its international patent application PCT/US 24/34252. The application covers the printing system of the company’s HD144 printer for plant-based fish, which is based on its proprietary DLS® (Drop Location in Space) drop-on-demand printing technology.

Nokia CorporationStock Exchange Release28 July 2025 at 15:00 EESTChanges in Nokia Corporation's own shares

SOMERSET, N.J., July 28, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Monday, August 11, 2025, to review second-quarter 2025 results.

Submission of NDA for LNZ100 in China by CORXEL Pharmaceuticals results in achievement of first milestone due to LENZ under the Development and Commercialization Agreement

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Fiserv, Inc. (“Fiserv” or the “Company”) (NYSE: FI) between July 24, 2024 and July 22, 2025, inclusive.

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) between December 12, 2024 and June 30, 2025, inclusive.

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Vestis Corporation (“Vestis” or the “Company”) (NYSE: VSTS) between May 2, 2024 and May 6, 2025, inclusive.

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS) between April 29, 2025 and June 22, 2025, inclusive.

Strategic partnership provides multi-location QSRs and enterprise restaurants with flexible payment technology to enhance omnichannel capabilities and simplify operations

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Petco Health and Wellness Company, Inc. (“Petco” or the “Company”) (NASDAQ: WOOF) between January 14, 2021 and June 5, 2025, inclusive.

Launched Strategy Toward AI-Driven Growth

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Apple Inc. (“Apple” or the “Company”) (NASDAQ: AAPL) between June 10, 2024 and June 9, 2025, inclusive.

Paving the Way for Broader Access and the First Combined CCM®/ICD System

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common units of XPLR Infrastructure, LP f/k/a NextEra Energy Partners, LP (“XPLR” or the “Company”) (NYSE: XIFR) between September 27, 2023 and January 27, 2025, inclusive.

ATLANTA, July 28, 2025 (GLOBE NEWSWIRE) -- Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), a clinical-stage biopharmaceutical company, focused on developing novel products for the treatment of Alzheimer’s disease (“Alzheimer’s”), bipolar disorder (“BD”), major depressive disorder (“MDD”) and post-traumatic stress disorder (“PTSD”), today announced it will have a poster presentation at the Military Health System Research Symposium (“MHSRS”), being held from August 4-7, 2025, in Orlando, Florida.

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Fortrea Holdings Inc. (“Fortrea” or the “Company”) (NASDAQ: FTRE) between July 3, 2023 and February 28, 2025, inclusive.

HOUSTON, July 28, 2025 (GLOBE NEWSWIRE) -- Great Lakes Dredge & Dock Corporation (NASDAQ: GLDD) today announced that it will release the financial results for its three months ended June 30, 2025, on Tuesday, August 5, 2025, at 7:00 a.m. C.D.T. A conference call with the Company will be held the same day at 9:00 a.m. C.D.T.

SAN DIEGO, July 28, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Luminar Technologies, Inc. (NASDAQ: LAZR) securities between March 20, 2025 and May 14, 2025. Luminar purports to be a technology company specializing in advanced LiDAR hardware and software solutions for vehicles.

Vertex's 2025 Mid-Year Report reveals more than 400 implemented changes to U.S. sales tax rates and rules nationwide, highlighting growing compliance complexity for businesses

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Sarepta Therapeutics, Inc. (“Sarepta” or the “Company”) (NASDAQ: SRPT) between June 22, 2023 and June 24, 2025, inclusive.

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR) between October 9, 2024 and July 10, 2025, inclusive.

NEWTON, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s disease (AD), today announced results showing that implementing a blood-based pTau217 screening assay reduced Acumen’s overall clinical trial screening costs by approximately 40% in its Phase 2 ALTITUDE-AD study of sabirnetug in early Alzheimer’s disease in the U.S. and Canada. Additionally, a nonclinical study revealed sabirnetug achieved the highest selectivity for AβOs over Aβ monomers relative to recombinant lecanemab and aducanumab. The results are being presented at the Alzheimer's Association International Conference (AAIC), taking place July 27-31, 2025, in Toronto and online.

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired: (a) Alto Neuroscience, Inc. (“Alto” or the “Company”) (NYSE: ANRO) common stock pursuant and/or traceable to the Offering Documents issued in connection with the Company’s initial public offering conducted on or about February 2, 2024 (the “IPO” or “Offering”); and/or (b) Alto securities between February 2, 2024 and October 22, 2024, both dates inclusive.

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) between November 7, 2024 and July 8, 2025, inclusive.

Top estate planning and probate attorney David Russ founder of DSR Legal, PLLC emphasizes the importance of understanding the probate process to ease the emotional and legal burdens families face after a loved one’s death. For more information, please visit https://dsrlegal.com/

Pi Coin risks a breakdown as LF Coin surges with strong tokenomics, utility, and 20 new listings by LF Labs this July 30.

PANAMA CITY, July 28, 2025 -- Crypto markets show bullish signs as LF Labs (LF Coin) prepares for major exchange listings and Dogecoin nears a key support. LF Labs is celebrating its 4th anniversary with 20 listings scheduled for July 30, boosting LF Coin visibility. Its strategic approach combines funding with market-making, supporting startups and fueling a sustainable token economy.

Lawrence Kajy, founder of Kajy Law, PLLC, has again been named to The National Trial Lawyers “Top 40 Under 40” Civil Plaintiff list in Michigan, honoring his exceptional leadership, trial success, and dedication to personal injury victims statewide.

Elite SEO Consulting was named a finalist at the 2025 US Search Awards for its low-budget SEO campaign, helping veteran-owned Wam Bam Handyman achieve page-one rankings and 10X ROI through strategic local optimization.

SohibSlot launches Indonesia’s first platform with live RTP display, daily slot predictions, and trusted game providers, offering fair play, high Maxwin potential, and a localized gaming experience amid Southeast Asia’s growing online gambling market.

IstanaSlot launches a transparency-focused campaign, featuring real-time RTP data, Maxwin-optimized gameplay, and global provider partnerships. Tailored for Indonesian users, it offers a secure, mobile-friendly slot experience aligned with Southeast Asia’s rising digital gaming trends.

Community Health Systems, Inc. (the “Company”) (NYSE: CYH) today announced that its wholly owned subsidiary, CHS/Community Health Systems, Inc. (the “Issuer”), has commenced a cash tender offer (the “Tender Offer”) for up to $1,470 million of the Issuer’s approximately $1,757 million aggregate principal amount outstanding 5.625% Senior Secured Notes due 2027 (the “2027 Notes”), on the terms and subject to the conditions set forth in the Issuer’s Offer to Purchase dated July 28, 2025.

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Neogen Corporation (NASDAQ: NEOG) common stock between January 5, 2023 and June 3, 2025, inclusive (the “Class Period”), have until September 16, 2025 to seek appointment as lead plaintiff of the Neogen class action lawsuit. Captioned Operating Engineers Construction Industry and Miscellaneous Pension Fund v. Neogen Corporation, No. 25-cv-00802 (W.D. Mich.), the Neogen class action lawsuit charges Neogen as well as certain of Neogen’s top executives with violations of the Securities Exchange Act of 1934.